Heparin LEO (Heparin Leo) Stungulyf, lausn 5000 a.e./ml アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

heparin leo (heparin leo) stungulyf, lausn 5000 a.e./ml

leo pharma a/s* - heparinum natricum inn - stungulyf, lausn - 5000 a.e./ml

Heparin LEO (Heparin Leo) Stungulyf, lausn 100 a.e./ml アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

heparin leo (heparin leo) stungulyf, lausn 100 a.e./ml

leo pharma a/s* - heparinum natricum inn - stungulyf, lausn - 100 a.e./ml

Protaminsulphat LEO Pharma Stungulyf, lausn 10 mg/ml アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

protaminsulphat leo pharma stungulyf, lausn 10 mg/ml

leo pharma a/s* - protamini sulfas inn - stungulyf, lausn - 10 mg/ml

Daivobet Hlaup 50 míkróg/g /0,5 mg/g アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

daivobet hlaup 50 míkróg/g /0,5 mg/g

leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - hlaup - 50 míkróg/g /0,5 mg/g

Fucidin-Hydrocortison Krem 20 + 10 mg アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

fucidin-hydrocortison krem 20 + 10 mg

leo pharma a/s* - acidum fusidicum inn; hydrocortisonum acetat - krem - 20 + 10 mg

Fucidin Smyrsli 20 mg/g アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

fucidin smyrsli 20 mg/g

leo pharma a/s* - natrii fusidas nfn - smyrsli - 20 mg/g

Fucidin Krem 20 mg/g アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

fucidin krem 20 mg/g

leo pharma a/s* - acidum fusidicum inn - krem - 20 mg/g

Daivobet Smyrsli 50 míkrog/g og 0,5 mg/g アイスランド - アイスランド語 - LYFJASTOFNUN (Icelandic Medicines Agency)

daivobet smyrsli 50 míkrog/g og 0,5 mg/g

leo pharma a/s* - calcipotriolum inn; betamethasonum díprópíónat - smyrsli - 50 míkrog/g og 0,5 mg/g

Picato 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

picato

leo laboratories ltd. - ingenol mebutate - keratósi, actinic - sýklalyf og chemotherapeutics fyrir húð notkun, Önnur chemotherapeutics - picato er ætlað fyrir húð meðferð ekki hyperkeratotic, ekki læknafélag geislunarhyrning í fullorðnir.

Protopic 欧州連合 - アイスランド語 - EMA (European Medicines Agency)

protopic

leo pharma a/s - takrólímus - dermatitis, atópísk - aðrar húðsjúkdómar - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. koma fjórir eða meira sinnum á ári) sem hafa haft fyrstu viðbrögð við sex vikur meðferð tvisvar á dag takrólímus smyrslið (sár ruddi, næstum ruddi eða dálítið áhrifum).